NextPlat Corp
NextPlat is a global e-commerce and healthcare services company headquartered in Hallandale Beach, Florida. It operates through e-Commerce Operations and Healthcare Operations, serving consumers, businesses, governments, healthcare providers, payors and institutions. Its e-commerce business sells satellite phones, tracking devices, broadband terminals and related equipment through three proprietary websites and third-party marketplace storefronts. It also earns recurring fees from satellite airtime, messaging and connectivity plans, and subscriptions to GTCTrack, a mapping and asset-tracking portal. Through its healthcare operations, NextPlat provides prescription and compounded medications, specialty and long-term care pharmacy services, medication therapy management, fulfillment for contracted government facilities, and pharmacy services for 340B covered entities. Its ClearMetrX subsidiary provides healthcare data management, analytics and reporting services. Pharmacies also offer delivery, provider support and medication packaging services.
No SEC Form 4 filings for $NXPL in the last 30 days.
See all $NXPL insider activity →NextPlat Corp reported a 35% gross margin and a 66% reduction in net loss year over year for Q3 2026. Gross profit improved nearly 35% and 340B prescription volumes grew 72%. The company expects to provide further details in its upcoming Form 10-Q.
NextPlat Corp's subsidiary, PharmcoRx, plans to launch automated prescription dispensing via VendRx kiosks in select clinics. The service aims to improve patient adherence and pharmacy growth by providing onsite prescription pickup. Initial deployments are expected in Q4 2026, with wider rollout in 2027. PharmcoRx believes this will expand its reach and prescription base.
NextPlat Corp. (NXPL) opened a new PharmcoRx pharmacy in Jacksonville, FL, expanding its network to six locations. The pharmacy offers prescription services, 340B program support, and specialty care. The company recently acquired a pharmacy near Pensacola for $1.49M, aiming to diversify its services and reduce reliance on single channels.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning NXPL (NextPlat Corp). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent NXPL coverage spans earnings, financial news and mergers & acquisitions.
Improved margins and lower loss suggest earnings beat potential.
The rollout creates a new revenue stream and could improve patient adherence, modestly boosting NXPL's growth outlook.
The new site supports incremental revenue and service-mix expansion (retail plus 340B, long-term care, and specialty services), which can modestly improve growth visibility in Florida.
The small acquisition adds modest revenue and expands pharmacy footprint in Florida.
The acquisition expands NextPlat's pharmacy footprint and adds a profitable unit, likely boosting near‑term earnings and margin outlook.
AlphAI scores every news story that mentions NXPL with an AI model for sentiment and relevance, and aggregates insider trades from NextPlat Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
NextPlat Corp reported a 35% gross margin and a 66% reduction in net loss year over year for Q3 2026. Gross profit improved nearly 35% and 340B prescription volumes grew 72%. The company expects to provide further details in its upcoming Form 10-Q.
NextPlat Corp's subsidiary, PharmcoRx, plans to launch automated prescription dispensing via VendRx kiosks in select clinics. The service aims to improve patient adherence and pharmacy growth by providing onsite prescription pickup. Initial deployments are expected in Q4 2026, with wider rollout in 2027. PharmcoRx believes this will expand its reach and prescription base.
NextPlat Corp. (NXPL) opened a new PharmcoRx pharmacy in Jacksonville, FL, expanding its network to six locations. The pharmacy offers prescription services, 340B program support, and specialty care. The company recently acquired a pharmacy near Pensacola for $1.49M, aiming to diversify its services and reduce reliance on single channels.
NextPlat Corp (NXPL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 NextPlat Completes Pensacola-Area Acquisition of Profitable Pharmacy, Accelerating Continued Healthcare Growth and Profitability Strategic Acquisition Enhances Pharmacy Diversification into Underserved Market, Supporting the Launch of New High-Value, High Margin Heal
NextPlat Corp (NXPL) completed the acquisition of a profitable pharmacy near Pensacola, Florida, for $1.49M. The pharmacy generated $5.6M in 2025 sales and is debt-free. NextPlat expects it to boost its PharmcoRx segment's growth and profitability. The company plans to integrate the pharmacy and expand its high-margin services in the region.
NextPlat Corp (NXPL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40% Growth Momentum Continues Across the Business, Highlighted by Increased Higher-Margin 340B Healthcare Prescription V
NextPlat Corp (NASDAQ: NXPL) reported Q2 2026 results ended June 30. Revenue was about $11.9M, up 21% sequentially. Net loss fell 92% to about $144K. Gross margin reached a record ~40% (Healthcare segment ~46%). Contracted pharmacy revenue rose 136% to ~$2.2M. The company also said it plans a Pensacola-area pharmacy acquisition.
NextPlat Corp (NASDAQ: NXPL) issued a mid-year 2026 shareholder update on its turnaround and growth plans. The company cited record consolidated gross margin of 35% for the quarter ended March 31, 2026, over $11M cash, and no material long-term debt. It reported 39% gross margin in Healthcare Operations, 340B prescriptions up over 70% YoY, and added six new 340B contracts in Q2. It also announced an acquisition of an independent pharmacy near Pensacola.
NextPlat Corp (NXPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex_988389.htm EXHIBIT 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT ex_988389.htm Exhibit 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among RON G. SCOTT, an individual and PROGRESSIVE CARE, LLC, a Nevada Limited Liability Company dated as of July 14 , 2026 Exhibits
NextPlat Corp (NASDAQ: NXPL) agreed to acquire an independent pharmacy near Pensacola, Florida for $1.5 million in cash and expects closing in Q4 2026. The pharmacy generated about $5.6 million in 2025 sales with ~19% retail margins. NextPlat says the deal adds about $5.6 million in profitable annual revenue and expands PharmcoRx’s 340B and contracted services.
